Cargando…
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
Influenza virus is a pathogen that causes morbidity and mortality worldwide. Whereas vaccination is important for prevention of disease, given its limitations, antiviral therapy is at the forefront of treatment and also plays a role in prevention. Currently, two classes of antiviral medications, the...
Autores principales: | Kamali, Amanda, Holodniy, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838482/ https://www.ncbi.nlm.nih.gov/pubmed/24277988 http://dx.doi.org/10.2147/IDR.S36601 |
Ejemplares similares
-
Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials
por: Shun-Shin, Matthew, et al.
Publicado: (2009) -
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
por: Kashiwagi, Seizaburo, et al.
Publicado: (2016) -
The role of neuraminidase inhibitors in the treatment and
prevention of influenza
por: Naem, Shahrour
Publicado: (2001) -
Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011) -
Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)